Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers describe findings in breast cancer studies
May 26th, 2005
Breast cancer research advances have been reported from the United States and Spain. Study 1: 5F 203 (2-(4-Amino-3-methylphenyl)-5-fluoro-benzothiazole) induces NF-kappa B activity in drug-sensitive human breast cancer MCF-7 cells. According to recent research from the United States, "5F 203 potently inhibits MCF-7 breast cancer cell growth in part by activating the aryl hydrocarbon receptor (AhR) signaling pathway. Ligands for the AhR (i.e. dioxin) have also been shown to modulate the NF-kappaB signaling cascade, affecting physiological processes such as cellular immunity, inflammation, proliferation and survival." "The objective...
Source: Women's Health Weekly (2005-05-26)
|
